Q&A Session on Omics and its relevance in understanding disease mechanisms | Agilent Technologies

Q&A Session on Omics and its relevance in understanding disease mechanisms | Agilent Technologies
By Agilent Technologies on December 11, 2020

In this video:
Q&A Session on Omics and its relevance in understanding disease mechanisms

Agilent Technologiesdisease mechanismsOmicsvirtual conference
Related Posts

Dr S. Karthick Prabhu, Secretary, IMA Tamil Nadu

Panel Discussion: Building a future-ready healthcare ecosystem

Dr Natesh B, COO, Lifeline Multispeciality Hospitals

Navaneeth Krishnan, Chief Executive Officer, Sanrad Infotech

Dr Abhishaanth Prabu, Medical Administrator, Be Well Hospitals

Mr Venkata Phanidhar, Group CEO, Medway Hospitals

Mr R. A. Nadesan, Director, SRM Group
Comments (0)
Add Comment